Effect of adenoviral transduction of the fragile histidine triad gene into esophageal cancer cells

Hideshi Ishii, Kristoffel R. Dumon, Andrea Vecchione, Francesco Trapasso, Koshi Mimori, Hansjuerg Alder, Masaki Mori, Gabriella Sozzi, Raffaele Baffa, Kay Huebner, Carlo M. Croce

Research output: Contribution to journalArticle

110 Citations (Scopus)

Abstract

Reintroduction of a tumor suppressor gene product in cancer cells is a promising strategy for cancer gene therapy. The fragile histidine triad (FHIT) gene has been identified in a region at chromosome 3p14.2, which is deleted in many tumors, including esophageal cancer. Previous studies have shown frequent biallelic alterations of the FHIT gene in numerous tumors, and have demonstrated a tumor suppressor function of Fhit. We have studied the biological effects of adenoviral-FHIT transduction in esophageal cancer cell lines. Results showed suppression of cell growth in vitro in three of seven esophageal cancer cell lines, all seven of which showed abundant expression of the transgene. Adenoviral-FHIT expression, but not control adenoviral infections, induced caspase-dependent apoptosis in two esophageal cancer cell lines, TE14 and TE4, which express no or very little Fhit, respectively. Treatment of TE14 cells with adenoviral-FHIT vectors resulted in abrogation of tumorigenicity in nude mice. A third esophageal cancer cell line, TE12, without detectable endogenous Fhit, showed accumulation of cells at S to G2-M and a small apoptotic cell fraction after adenoviral-FHIT transduction. Thus, adenoviral-FHIT expression can inhibit the growth of esophageal cancer cells, at least in part through caspase-dependent apoptosis, suggesting that adenoviral-FHIT infection should be explored as a therapeutic strategy.

Original languageEnglish
Pages (from-to)1578-1584
Number of pages7
JournalCancer Research
Volume61
Issue number4
Publication statusPublished - Feb 15 2001

Fingerprint

Esophageal Neoplasms
Histidine
Genes
Cell Line
Caspases
Neoplasms
Apoptosis
Neoplasm Genes
Infection Control
Growth
Tumor Suppressor Genes
Transgenes
Nude Mice
Genetic Therapy
Chromosomes
Therapeutics
Infection

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Ishii, H., Dumon, K. R., Vecchione, A., Trapasso, F., Mimori, K., Alder, H., ... Croce, C. M. (2001). Effect of adenoviral transduction of the fragile histidine triad gene into esophageal cancer cells. Cancer Research, 61(4), 1578-1584.

Effect of adenoviral transduction of the fragile histidine triad gene into esophageal cancer cells. / Ishii, Hideshi; Dumon, Kristoffel R.; Vecchione, Andrea; Trapasso, Francesco; Mimori, Koshi; Alder, Hansjuerg; Mori, Masaki; Sozzi, Gabriella; Baffa, Raffaele; Huebner, Kay; Croce, Carlo M.

In: Cancer Research, Vol. 61, No. 4, 15.02.2001, p. 1578-1584.

Research output: Contribution to journalArticle

Ishii, H, Dumon, KR, Vecchione, A, Trapasso, F, Mimori, K, Alder, H, Mori, M, Sozzi, G, Baffa, R, Huebner, K & Croce, CM 2001, 'Effect of adenoviral transduction of the fragile histidine triad gene into esophageal cancer cells', Cancer Research, vol. 61, no. 4, pp. 1578-1584.
Ishii H, Dumon KR, Vecchione A, Trapasso F, Mimori K, Alder H et al. Effect of adenoviral transduction of the fragile histidine triad gene into esophageal cancer cells. Cancer Research. 2001 Feb 15;61(4):1578-1584.
Ishii, Hideshi ; Dumon, Kristoffel R. ; Vecchione, Andrea ; Trapasso, Francesco ; Mimori, Koshi ; Alder, Hansjuerg ; Mori, Masaki ; Sozzi, Gabriella ; Baffa, Raffaele ; Huebner, Kay ; Croce, Carlo M. / Effect of adenoviral transduction of the fragile histidine triad gene into esophageal cancer cells. In: Cancer Research. 2001 ; Vol. 61, No. 4. pp. 1578-1584.
@article{a7ea17767df247ce96b5421693124426,
title = "Effect of adenoviral transduction of the fragile histidine triad gene into esophageal cancer cells",
abstract = "Reintroduction of a tumor suppressor gene product in cancer cells is a promising strategy for cancer gene therapy. The fragile histidine triad (FHIT) gene has been identified in a region at chromosome 3p14.2, which is deleted in many tumors, including esophageal cancer. Previous studies have shown frequent biallelic alterations of the FHIT gene in numerous tumors, and have demonstrated a tumor suppressor function of Fhit. We have studied the biological effects of adenoviral-FHIT transduction in esophageal cancer cell lines. Results showed suppression of cell growth in vitro in three of seven esophageal cancer cell lines, all seven of which showed abundant expression of the transgene. Adenoviral-FHIT expression, but not control adenoviral infections, induced caspase-dependent apoptosis in two esophageal cancer cell lines, TE14 and TE4, which express no or very little Fhit, respectively. Treatment of TE14 cells with adenoviral-FHIT vectors resulted in abrogation of tumorigenicity in nude mice. A third esophageal cancer cell line, TE12, without detectable endogenous Fhit, showed accumulation of cells at S to G2-M and a small apoptotic cell fraction after adenoviral-FHIT transduction. Thus, adenoviral-FHIT expression can inhibit the growth of esophageal cancer cells, at least in part through caspase-dependent apoptosis, suggesting that adenoviral-FHIT infection should be explored as a therapeutic strategy.",
author = "Hideshi Ishii and Dumon, {Kristoffel R.} and Andrea Vecchione and Francesco Trapasso and Koshi Mimori and Hansjuerg Alder and Masaki Mori and Gabriella Sozzi and Raffaele Baffa and Kay Huebner and Croce, {Carlo M.}",
year = "2001",
month = "2",
day = "15",
language = "English",
volume = "61",
pages = "1578--1584",
journal = "Journal of Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "4",

}

TY - JOUR

T1 - Effect of adenoviral transduction of the fragile histidine triad gene into esophageal cancer cells

AU - Ishii, Hideshi

AU - Dumon, Kristoffel R.

AU - Vecchione, Andrea

AU - Trapasso, Francesco

AU - Mimori, Koshi

AU - Alder, Hansjuerg

AU - Mori, Masaki

AU - Sozzi, Gabriella

AU - Baffa, Raffaele

AU - Huebner, Kay

AU - Croce, Carlo M.

PY - 2001/2/15

Y1 - 2001/2/15

N2 - Reintroduction of a tumor suppressor gene product in cancer cells is a promising strategy for cancer gene therapy. The fragile histidine triad (FHIT) gene has been identified in a region at chromosome 3p14.2, which is deleted in many tumors, including esophageal cancer. Previous studies have shown frequent biallelic alterations of the FHIT gene in numerous tumors, and have demonstrated a tumor suppressor function of Fhit. We have studied the biological effects of adenoviral-FHIT transduction in esophageal cancer cell lines. Results showed suppression of cell growth in vitro in three of seven esophageal cancer cell lines, all seven of which showed abundant expression of the transgene. Adenoviral-FHIT expression, but not control adenoviral infections, induced caspase-dependent apoptosis in two esophageal cancer cell lines, TE14 and TE4, which express no or very little Fhit, respectively. Treatment of TE14 cells with adenoviral-FHIT vectors resulted in abrogation of tumorigenicity in nude mice. A third esophageal cancer cell line, TE12, without detectable endogenous Fhit, showed accumulation of cells at S to G2-M and a small apoptotic cell fraction after adenoviral-FHIT transduction. Thus, adenoviral-FHIT expression can inhibit the growth of esophageal cancer cells, at least in part through caspase-dependent apoptosis, suggesting that adenoviral-FHIT infection should be explored as a therapeutic strategy.

AB - Reintroduction of a tumor suppressor gene product in cancer cells is a promising strategy for cancer gene therapy. The fragile histidine triad (FHIT) gene has been identified in a region at chromosome 3p14.2, which is deleted in many tumors, including esophageal cancer. Previous studies have shown frequent biallelic alterations of the FHIT gene in numerous tumors, and have demonstrated a tumor suppressor function of Fhit. We have studied the biological effects of adenoviral-FHIT transduction in esophageal cancer cell lines. Results showed suppression of cell growth in vitro in three of seven esophageal cancer cell lines, all seven of which showed abundant expression of the transgene. Adenoviral-FHIT expression, but not control adenoviral infections, induced caspase-dependent apoptosis in two esophageal cancer cell lines, TE14 and TE4, which express no or very little Fhit, respectively. Treatment of TE14 cells with adenoviral-FHIT vectors resulted in abrogation of tumorigenicity in nude mice. A third esophageal cancer cell line, TE12, without detectable endogenous Fhit, showed accumulation of cells at S to G2-M and a small apoptotic cell fraction after adenoviral-FHIT transduction. Thus, adenoviral-FHIT expression can inhibit the growth of esophageal cancer cells, at least in part through caspase-dependent apoptosis, suggesting that adenoviral-FHIT infection should be explored as a therapeutic strategy.

UR - http://www.scopus.com/inward/record.url?scp=0035866368&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035866368&partnerID=8YFLogxK

M3 - Article

VL - 61

SP - 1578

EP - 1584

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

IS - 4

ER -